Ledger.Open graph →
SEC Form D · filed August 23, 2022

Orna Therapeutics Holdings, LLC

Offering
$300.0M
Sold
$120.6M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (25)

Sakae M. Asanuma · Cambridge, MADirectorBrian M. Goodman · Cambridge, MADirectorThomas M. Ebeling · Cambridge, MADirectorRobert M. Marby · Cambridge, MAExecJohn M. Mccabe · Cambridge, MAExecSakae M. Asanuma · Cambridge, MADirectorFrancesco M. Marincola · Cambridge, MADirectorThomas M. Ebeling · Cambridge, MADirectorFrancesco M. Marincola · Cambridge, MADirectorBrian M. Goodman · Cambridge, MADirectorJohn M. Mccabe · Cambridge, MAExecJohn M. Mccabe · Cary, NCExecNishla M. Keiser · Cambridge, MAExecRobert M. Marby · Cambridge, MAExecDaniel M. Anderson · Cambridge, MADirectorThomas M. Barnes · Cambridge, MAExec · DirectorAnsbert M. Gadicke · Cambridge, MADirectorNishla M. Keiser · Cambridge, MAExecMorana M. Jovan-Embiricos · Cambridge, MADirectorMorana M. Jovan-Embiricos · Cambridge, MADirectorWilliam M. Shen · Cambridge, MAExecAnsbert M. Gadicke · Cambridge, MADirectorWilliam M. Shen · Cambridge, MAExecThomas M. Barnes · Cambridge, MAExec · DirectorDaniel M. Anderson · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗